Log in to save to my catalogue

The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of...

The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10915986

The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of Alzheimer's disease

About this item

Full title

The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of Alzheimer's disease

Publisher

England: John Wiley & Sons, Inc

Journal title

CNS neuroscience & therapeutics, 2024-03, Vol.30 (3), p.e14188-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Introduction
In the present study, we assessed the effects of the hyper‐harmonized‐hydroxylated fullerene–water complex (3HFWC) on Alzheimer's disease (AD) neuropathological hallmarks in 5XFAD mice, an AD animal model.
Methods
The 3‐week‐old 5XFAD mice were exposed to 3HFWC water solution ad libitum for 3 months in the presymptomatic phase...

Alternative Titles

Full title

The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10915986

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10915986

Other Identifiers

ISSN

1755-5930

E-ISSN

1755-5949

DOI

10.1111/cns.14188

How to access this item